Any feedback?
Literature summary for 3.4.22.14 extracted from
- Immunoglobulin E recognition patterns to purified Kiwifruit (Actinidinia deliciosa) allergens in patients sensitized to Kiwi with different clinical symptoms (2008), Clin. Exp. Allergy, 38, 1220-1228.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | to isolate major kiwifruit allergens a large group of kiwi-sensitized patients with different clinical symptoms are investigated. The three major IgE-binding proteins from kiwifruit extracts are isolated and characterized. The isolated kiwifruit allergens are: actinidin Act d 1, glycosylated thaumatin-like Act d 2 and a novel 40 kDa glycoprotein designated as Act d 3.02. Specific IgE to each of the three allergens is found in over 60% of sera from kiwi-sensitized patients, and Act d 1 and Act d 2 induces positive SPT responses in over 50% of the tested patients. A significant link between IgE levels to Act d 1 and Act d 3 and anaphylaxis is uncovered. Act d 1, Act d 2 and Act d 3 are major allergens in the population studied. Severe symptoms after kiwi ingestion are associated with high IgE levels to Act d 1 and Act d 3 | Actinidia deliciosa |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Actinidia deliciosa | - |
- |
- |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| actinidin | - |
Actinidia deliciosa |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
